Serail Pharmalab India Limited, a struck off public limited company, was established on 10 July 2008 in Mumbai, Maharashtra, India. Engaging in industrial machinery retail & distribution within the machinery and equipment sector, it holds CIN: U24239MH2008PLC184479. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Nitin Purushottam Shah (Director), Karnik Kantilal Parikh (Director), Umesh Purushottam Shah (Director). Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Kasturi,Sanghviestategovandistationroad,Govandi(East), Mumbai, Maharashtra, 400088.
U24239MH2008PLC184479
184479
10 July 2008
₹1.00 Cr
₹0.50 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Serail Pharmalab India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nitin Purushottam Shah | Director | 10 Jul 2008 | Current |
| Karnik Kantilal Parikh | Director | 10 Jul 2008 | Current |
| Umesh Purushottam Shah | Director | 10 Jul 2008 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Serail Pharmalab India Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 77.39% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Serail Pharmalab India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Serail Pharmalab India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Serail Pharmalab India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serail Pharmalab India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Serail Pharmalab India Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
Serail Pharmalab India Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was recorded as a recent event.
The activity Nitin Purushottam Shah was appointed as a Director was appointed as a Director on 10 Jul 2008 & has been associated with this company since 17 years 4 months . was completed.
The activity Karnik Kantilal Parikh was appointed as a Director was appointed as a Director on 10 Jul 2008 & has been associated with this company since 17 years 4 months . was completed.
Umesh Purushottam Shah was appointed as a Director was appointed as a Director on 10 Jul 2008 & has been associated with this company since 17 years 4 months . was recorded as a recent event.
Progress on Serail Pharmalab India Limited was registered on 10 Jul 2008 with Roc Mumbai & aged 17 years 4 months as per MCA records. was documented.
The CIN of Serail Pharmalab India Limited is U24239MH2008PLC184479.
Serail Pharmalab India Limited is headquartered at Kasturi,Sanghviestategovandistationroad,Govandi(East), Mumbai, Maharashtra, 400088.
Serail Pharmalab India Limited was incorporated on 10 July 2008.
The current directors of Serail Pharmalab India Limited are
The primary industry of Serail Pharmalab India Limited is Machinery And Equipment.
Serail Pharmalab India Limited is unlisted.
The authorized capital of Serail Pharmalab India Limited is ₹1.00 Cr, and the paid-up capital is ₹0.50 M.
The compliance status of Serail Pharmalab India Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX